Last week Tony Coker met Mykola Nikolaev, the CEO at Oximio, and discussed Africa as a promising business destination. Surprisingly, there still isn’t a pharmaceutical company that has built its core business model centered around Africa… Both Tony and Mykola agreed that being the first to do so would benefit significantly from the continent’s growing economy.
Africa is a diverse continent, with many opportunities unexplored. The notion of ‘exoticism’ can inadvertently cast a shadow on Africa, potentially causing people to overlook the incredible potential of its people and business prospects. While Africa has stunning natural beauty and rich cultural diversity, the thing that fuels African business is primarily driven by its people and their unwavering enthusiasm for the continent’s progress
Colonial history has left a lasting impact on Africa, often reducing it to a mere resource-rich region. Unfortunately, this outdated perception persists.
Both Tony and Mykola have a mission to reshape this perception by bolstering the pharmaceutical business.
Tony remarked, ‘Mykola, I can see the fire in your eyes when it comes to Africa’s potential!’